# A Bianli

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/a-bianli

- Industry: Healthcare IT
- Headquarters: Shenzhen, China
- Website: www.infynova.com
- Total disclosed funding: $0.8M
- Latest round: Series A (Nov 3, 2021)
- Investors on record: 5

## About

A Bianli, based in Shenzhen, China, is a medical equipment company specializing in innovative smart supply chain solutions tailored for high-value medical consumables, enhancing operational efficiency in healthcare logistics.Founded in 2017 in Shenzhen, China, A Bianli focuses on optimizing supply chain management for medical consumables. The company has completed 4 deals, with its most recent being an Angel round in November 2021, raising CNY 5.000 mn led by K2VC. The founder, Heshan Li, has a background in spearheading technological innovations in the healthcare sector.A Bianli specializes in providing intelligent supply chain solutions for high-value medical consumables. Their offerings include a comprehensive platform that enhances operational efficiency and compliance, significantly reducing manual processes and optimizing inventory management for healthcare providers and distributors. This technology addresses critical logistics challenges, ensuring timely delivery and compliance with regulations, targeting clients such as hospitals and medical device manufacturers in urban centers across China and potentially in Southeast Asia.Revenue generation for A Bianli operates through B2B partnerships with hospitals and distributors, involving service fees from tailored supply chain solutions. Their flagship products include intelligent supply chain platforms and specialized warehouse management systems, with transactions based on project setups followed by ongoing maintenance and support fees. The pricing is tailored to client needs and service complexity, fostering stable revenue streams and long-term relationships with key healthcare stakeholders.A Bianli aims to expand its product offerings by designing new supply chain management solutions, with plans for release in the coming year. The company is targeting expansion into Southeast Asian markets by 2023, leveraging recent funding from their Angel round in November 2021 to support these initiatives. This funding will be used to enhance product development and establish a presence in new geographic regions.

## Funding rounds

- Series A, Nov 3, 2021 — GSR Ventures
- Series A, Jan 8, 2021 — Plum Ventures, Qixi Investment
- Angel, Dec 7, 2017, $0.8M — K2VC, Next Capital

## Investors

- K2VC (https://capitalatlas.ai/funds/k2vc) — Angel
- Next Capital — Angel
- Plum Ventures (https://capitalatlas.ai/funds/plum-ventures) — Series A
- Qixi Investment — Series A
- GSR Ventures (https://capitalatlas.ai/funds/gsr-ventures) — Series A